Resistência ao tratamento no linfoma de Burkitt: associação com mutações específicas no gene TP53? Treatment resistance in Burkitt's lymphoma: is it associated with specific mutations of the TP53 gene?
O linfoma de Burkitt (LB) surge a partir de uma célula do centro germinativo que perde o controle da proliferação devido à ativação do gene c-myc. A resistência à apoptose é uma causa importante da falha à quimioterapia na maioria dos cânceres e também no LB. A taxa alta de apoptose observada no LB...
المؤلفون الرئيسيون: | Eliane P. S. Magluta, Claudete E. Klumb |
---|---|
التنسيق: | مقال |
اللغة: | English |
منشور في: |
Elsevier
2008-02-01
|
سلاسل: | Revista Brasileira de Hematologia e Hemoterapia |
الموضوعات: | |
الوصول للمادة أونلاين: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842008000100011 |
مواد مشابهة
-
Linfoma de Burkitt axilar
حسب: Sonia María Morón Losada, وآخرون
منشور في: (2021-04-01) -
Linfoma burkitt de tiroides
حسب: Alvaro Pereyra Zenklusen, وآخرون
منشور في: (2011-07-01) -
Linfoma de Burkitt abdominal
حسب: José Ridal González Álvarez, وآخرون
منشور في: (2014-04-01) -
Linfoma de Burkitt Burkitt lymphoma
حسب: Fernando Sierra Arego, وآخرون
منشور في: (2012-03-01) -
Case report: Sandwich therapy of CAR-T combined with ASCT: Sequential CAR-T cell therapy with ASCT after remission with CAR-T therapy caused long-term survival in a patient with relapsed/refractory Burkitt’s lymphoma with TP53 mutations
حسب: Qi Zhang, وآخرون
منشور في: (2023-03-01)